InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
T+90 hit rate
21%
T+90 mean return
-8.8%
Across 14 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Jacobs Bruce N., Chief Financial Officer. Officer active across 2 companies, notably Kymera Therapeutics, Inc.. Aggregated, 23 disclosures have been logged. Activity tracked since 3 June 2021. The latest transaction was filed on 31 March 2025 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations23 total
25,000 shares@ US$2.0814.3% of flowCommon StockSEC:0000950170-25-048049:0
30,000 shares0Common StockSEC:0000950170-25-031146:0
10,000 shares@ US$2.086.0% of flowCommon StockSEC:0000950170-25-004548:0
25,000 shares@ US$2.0814.5% of flowCommon StockSEC:0000950170-24-078790:0
31,250 shares0Common StockSEC:0000950170-24-025083:0
10,000 shares@ US$2.085.8% of flowCommon StockSEC:0000950170-23-025989:0
23,750 shares0Common StockSEC:0000899243-23-006979:0
10,000 shares@ US$2.086.3% of flowCommon StockSEC:0000899243-22-033996:0
10,000 shares@ US$2.086.3% of flowCommon StockSEC:0000899243-22-033710:0
20,000 shares@ US$2.080.0006% mcap25.2% of flowCommon StockSEC:0000899243-22-016429:0
13,300 shares0Common StockSEC:0000899243-22-009078:0
10,000 shares@ US$2.080.0003% mcap11.6% of flowCommon StockSEC:0000899243-22-002016:0
15,000 shares@ US$2.080.0004% mcap17.5% of flowCommon StockSEC:0000899243-22-002010:0
15,000 shares@ US$2.080.0004% mcap23.4% of flowCommon StockSEC:0000899243-22-002010
10,000 shares@ US$2.080.0003% mcap15.5% of flowCommon StockSEC:0000899243-22-002016
10,000 shares@ US$2.080.0003% mcap11.7% of flowCommon StockSEC:0000899243-21-046845:0
10,000 shares@ US$2.0815.7% of flowCommon StockSEC:0000899243-21-046845
10,000 shares@ US$2.080.0003% mcap11.8% of flowCommon StockSEC:0000899243-21-045803:0
10,000 shares@ US$2.0815.8% of flowCommon StockSEC:0000899243-21-045803
10,000 shares@ US$2.080.0003% mcap11.2% of flowCommon StockSEC:0000899243-21-035158:0
10,000 shares@ US$2.0814.9% of flowCommon StockSEC:0000899243-21-035158
10,000 shares@ US$2.080.0003% mcap10.9% of flowCommon StockSEC:0000899243-21-022025:0
10,000 shares@ US$2.0814.6% of flowCommon StockSEC:0000899243-21-022025
23 of 23 declarations
About Jacobs Bruce N.
Bruce N. Jacobs is the Chief Financial Officer of Kymera Therapeutics, Inc. He is responsible for the financial management of the company, including budgeting and financial performance analysis. His role is essential in ensuring Kymera's financial health and supporting its strategic initiatives. Bruce also contributes to the development of the company's overall financial strategy.
